News
HYDERABAD: Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant Sanofi’s Indian arm, Sanofi Healthcare India Pvt Ltd (SHIPL), to bring a ...
Dr. Reddy’s Laboratories will expand its partnership with Sanofi Healthcare India (SHIPL) by launching the latter’s novel drug Beyfortus (nirsevimab) in India. Containing monoclonal antibody ...
Shares of Dr. Reddy's Laboratories Ltd. 500124 slid 1.95% to 1,176.25 Indian rupees Tuesday, on what proved to be an all-around positive trading session for the stock market, with the BSE SENSEX ...
Dr Reddy's Laboratories on Monday said it has expanded its partnership with Sanofi Healthcare to introduce a novel drug for the prevention of lower respiratory tract disease in newborns.
Dr Reddy’s Laboratories expands its strategic partnership with Sanofi Healthcare India to introduce a novel drug, Beyfortus (nirsevimab), in India. Beyfortus contains the monoclonal antibody, ...
HYDERABAD: Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant ...
Dr. Reddy's Laboratories has expanded its partnership with Sanofi Healthcare to introduce Beyfortus, a novel drug preventing ...
The award recognises his contributions in the field of medicine. Dr. Reddy, who serves as the chairman of the Asian Institute of Gastroenterology (AIG) in Hyderabad, is among seven persons to ...
OAK BROOK, IL – Dr. Suresh Reddy was re-elected as a Trustee for Oak Brook Township, Illinois, alongside Jim Nagle and Dr. Melissa Martin, in the April 1 elections. Four candidates vied for ...
Shares of Bajaj Finance, Bajaj Finserv, Trent, Ambuja, BPCL, and NTPC Green are likely to be in the focus as these companies are set to announce their fourth-quarter results.
However, analysts anticipate higher sales of Revlimid to drive growth for US-focused companies such as Aurobindo Pharma Ltd, Dr Reddy’s Laboratories Ltd and Sun Pharmaceutical Industries Ltd in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results